BD drug susceptibility test inoculum
Taiwan·Risk Class 2·BECTON DICKINSON AND COMPANY·Registered Jun 13, 2022 – Jun 13, 2027Active- Analysis ID
- 4b2fb839c66a64ef39bdc737f58dd232
- Customs Code
- DHA05603566509
- Manufacturer
- BECTON DICKINSON AND COMPANY
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- This product is intended for use with the BD Phoenix Gram Positive and BD Phoenix Gram Negative reagent sets.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1645 Automatic Antibiotic Sensitivity Test System for Short Incubation Period
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Jun 13, 2022
- Expiry Date
- Jun 13, 2027
Top companies providing products similar to "BD drug susceptibility test inoculum"
Recently registered similar products
Access comprehensive regulatory information for BD drug susceptibility test inoculum in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4b2fb839c66a64ef39bdc737f58dd232 and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including BECTON DICKINSON AND COMPANY, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.